Literature DB >> 18350294

Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.

Nathalie Douet-Guilbert1, Audrey Basinko, Frédéric Morel, Marie-Josée Le Bris, Valérie Ugo, Patrick Morice, Christian Berthou, Marc De Braekeleer.   

Abstract

Deletion of the long arm of chromosome 20 is a recurrent abnormality observed in myelodysplastic syndromes (MDS) and in Philadelphia-chromosome-negative myeloproliferative disorders (MPD). Our objective was to characterize the deletion size among 38 MDS and MPD patients using fluorescence in situ hybridization (FISH) with bacterial artificial chromosome (BAC) probes and to define commonly deleted and retained regions on chromosome 20. Patients were distributed in three groups according to the World Health Organization classification: MDS (22 patients), MPD (12 patients) and myelodysplastic/myeloproliferative diseases (four patients). FISH with centromeric, subtelomeric, and unique sequence probes was performed to characterize the deletion whereas its size was delineated using BAC clones. All 38 deletions were found to be interstitial. A commonly deleted region was identified for each of the three groups; it varied from 6.62 to 10.4 Mb and showed considerable overlapping. Two commonly retained regions (CRR), also showing overlapping, were identified in all three groups, one in the centromeric region, the other in the telomeric region. The deletion size is highly variable, with no apparent recurrent breakpoint. The deletion may result in the loss of one or several tumor suppressor genes but the target genes remain unknown. Loss of genes plays an important part in the myeloid leukemic process associated with del(20q). However, genes located in the retained chromosomal regions may also play a role in the oncogenetic mechanisms.

Entities:  

Mesh:

Year:  2008        PMID: 18350294     DOI: 10.1007/s00277-008-0462-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  9 in total

1.  Microarray CGH analysis of hematological patients with del(20q).

Authors:  Chunxiao Wu; Jinlan Pan; Huiying Qiu; Yongquan Xue; Suning Chen; Yafang Wu; Jun zhang; Shuxiao Bai; Yong Wang; Juan Shen; Yanlei Gong
Journal:  Int J Hematol       Date:  2015-10-06       Impact factor: 2.490

2.  Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.

Authors:  Hayan Jouni; Khader Shameer; Yan W Asmann; Ribhi Hazin; Mariza de Andrade; Iftikhar J Kullo
Journal:  J Investig Med       Date:  2013-10       Impact factor: 2.895

3.  Dido mutations trigger perinatal death and generate brain abnormalities and behavioral alterations in surviving adult mice.

Authors:  Ricardo Villares; Julio Gutiérrez; Agnes Fütterer; Varvara Trachana; Fernando Gutiérrez del Burgo; Carlos Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

4.  Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis.

Authors:  Kathy L McGraw; Chia-Ho Cheng; Y Ann Chen; Hsin-An Hou; Björn Nilsson; Giulio Genovese; Thomas Cluzeau; Andrea Pellagatti; Bartlomiej P Przychodzen; Mar Mallo; Leonor Arenillas; Azim Mohamedali; Lionel Adès; David A Sallman; Eric Padron; Lubomir Sokol; Chimene Moreilhon; Sophie Raynaud; Hwei-Fang Tien; Jacqueline Boultwood; Benjamin L Ebert; Francesc Sole; Pierre Fenaux; Ghulam J Mufti; Jaroslaw P Maciejewski; Peter A Kanetsky; Alan F List
Journal:  Blood Adv       Date:  2019-11-26

5.  Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory.

Authors:  Etienne De Braekeleer; Claus Meyer; Nathalie Douet-Guilbert; Audrey Basinko; Marie-Josée Le Bris; Frédéric Morel; Christian Berthou; Rolf Marschalek; Claude Férec; Marc De Braekeleer
Journal:  Mol Oncol       Date:  2011-08-26       Impact factor: 6.603

Review 6.  Using bacterial artificial chromosomes in leukemia research: the experience at the university cytogenetics laboratory in Brest, France.

Authors:  Etienne De Braekeleer; Nathalie Douet-Guilbert; Audrey Basinko; Frédéric Morel; Marie-Josée Le Bris; Claude Férec; Marc De Braekeleer
Journal:  J Biomed Biotechnol       Date:  2011-01-11

7.  SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis.

Authors:  Giuseppe Visani; Maria Rosaria Sapienza; Alessandro Isidori; Claudio Tripodo; Maria Antonella Laginestra; Simona Righi; Carlo A Sagramoso Sacchetti; Anna Gazzola; Claudia Mannu; Maura Rossi; Michele De Nictolis; Massimo Valentini; Meris Donati; Roberto Emiliani; Francesco Alesiani; Stefania Paolini; Carlo Finelli; Stefano A Pileri; Pier Paolo Piccaluga
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

8.  Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation.

Authors:  Samuel A Stoner; Ming Yan; Katherine Tin Heng Liu; Kei-Ichiro Arimoto; Takahiro Shima; Huan-You Wang; Daniel T Johnson; Rafael Bejar; Catriona Jamieson; Kun-Liang Guan; Dong-Er Zhang
Journal:  Blood       Date:  2019-11-14       Impact factor: 25.476

9.  Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.

Authors:  Hayan Jouni; Khader Shameer; Yan W Asmann; Ribhi Hazin; Mariza de Andrade; Iftikhar J Kullo
Journal:  J Investig Med High Impact Case Rep       Date:  2013-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.